🔎 Trials Near Me

Dachaigh › Cancer Ovarian › Ohio › Cincinnati

Sgrùdaidhean clionaigeach Cancer Ovarian ann an Cincinnati, OH

Tha 19 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Cincinnati (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

A’ fastadhÌre 2
  • Good Samaritan Hospital - Cincinnati, Cincinnati
Gach aois · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564377

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

A’ fastadhÌre 2
  • University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 1 Dàmh 2026 · NCT07024784

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A’ fastadhÌre 2
  • Site 0147 - Trihealth Cancer Institute - Harold and Eugen, Cincinnati
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05128825

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

A’ fastadhÌre 2
  • Research Site, Cincinnati
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

A’ fastadhÌre 3
  • University of Cincinnati Medical Center, Cincinnati
  • Oncology Hematology Care Inc, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07213804

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

A’ fastadhÌre 3
  • University of Cincinnati Medical Center ( Site 0042), Cincinnati
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

A’ fastadhÌre 3
  • St Elizabeth Healthcare, Edgewood · 8 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 15 Sult 2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

A’ fastadhÌre 2
  • Oncology Hematology Care, Inc, Cincinnati
Aoisean 18 gu 99 · Banairean · Air ùrachadh 15 Sult 2026 · NCT07023627

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

A’ fastadhÌre 1/2
  • Christ Hospital, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06303505

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

A’ fastadhÌre 3
  • University of Cincinnati Medical Center ( Site 0090), Cincinnati
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 3 Sult 2026 · NCT06824467

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

A’ fastadhÌre 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

A’ fastadhÌre 1
  • St. Elizabeth Healthcare, Edgewood · 8 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06774963

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

A’ fastadh
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • agus 3 a bharrachd
Aoisean 35 gu 50 · Banairean · Air ùrachadh 7 Lùna 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

A’ fastadhÌre 3
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • TriHealth Cancer Institute-Westside, Cincinnati
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06580314

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Oncology Hematology Care Primary, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

A’ fastadhÌre 2/3
  • St. Elizabeth Medical Center, Edgewood · 8 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT06161025

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

A’ fastadhÌre 3
  • University of Cincinnati Medical Center, Cincinnati
  • TriHealth Cancer Institute - Good Samaritan Hospital, Cincinnati
  • TriHealth Cancer Institute- Thomas Comprehensive Care Center, Cincinnati
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 16 Gibl 2026 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Cincinnati
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Sgrùdaidhean Cancer Ovarian ann am bailtean eile

Sgrùdaidhean eile ann an Cincinnati

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.